Nitto Denko Avecia to Evaluate EnPlusOne’s ezRNA Platform
A partnership will evaluate EnPlusOne’s ezRNA platform for RNA therapeutics manufacturing, connecting its expanded RNA chemistry and scalable enzymatic synthesis with Avecia.
A partnership will evaluate EnPlusOne’s ezRNA platform for RNA therapeutics manufacturing, connecting its expanded RNA chemistry and scalable enzymatic synthesis with Avecia.